TLCR Reading Tools
How to cite item
Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{64881}, author = {Liu, Q., Xu, J., Xu, Y., Chen, M., Deng, L., Wu, J., Zhou, T., Zhang, L., Tan, J., Pu, X., Shang, Y., Hua, J., Li, Y., Cai, W., Gu, Y., Peng, X., Chan, P., Jabbour, S., Nam, H., Hua, D.}, title = {Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial}, journal = {Translational Lung Cancer Research}, volume = {11}, number = {5}, year = {2022}, url = {https://tlcr.amegroups.org/article/view/64881} }